Effects of Tazarotene 0.045% Lotion on Quality of Life in Patients With Moderate-to-Severe Acne.

CONCLUSIONS: Participants treated with tazarotene 0.045% lotion had significant quality-of-life improvements. Clinician-rated symptom severity appeared to have a smaller effect on Acne-QoL outcomes than participants’ own assessments of quality of life. J Drugs Dermatol. 2020;19(11): doi:10.36849/JDD.2020.5457.
PMID: 33196747 [PubMed - in process]

Source: Journal of Drugs in Dermatology - November 19, 2020 Category: Dermatology Tags: J Drugs Dermatol Source Type: research